ID: ALA5290663

Max Phase: Preclinical

Molecular Formula: C20H18N4S

Molecular Weight: 346.46

Associated Items:

Representations

Canonical SMILES:  CN(C)c1ccc2cc(-c3nc(-c4ccccc4)cs3)c(N)nc2c1

Standard InChI:  InChI=1S/C20H18N4S/c1-24(2)15-9-8-14-10-16(19(21)22-17(14)11-15)20-23-18(12-25-20)13-6-4-3-5-7-13/h3-12H,1-2H3,(H2,21,22)

Standard InChI Key:  TWBTWIXIIRZCBP-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania mexicana 936 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

J774.A1 2436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 346.46Molecular Weight (Monoisotopic): 346.1252AlogP: 4.67#Rotatable Bonds: 3
Polar Surface Area: 55.04Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.10CX LogP: 4.72CX LogD: 4.55
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.59Np Likeness Score: -1.34

References

1. Hammill JT, Sviripa VM, Kril LM, Ortiz D, Fargo CM, Kim HS, Chen Y, Rector J, Rice AL, Domagalska MA, Begley KL, Liu C, Rangnekar VM, Dujardin JC, Watt DS, Landfear SM, Guy RK..  (2021)  Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents.,  64  (16.0): [PMID:34355566] [10.1021/acs.jmedchem.1c00813]

Source